BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31204921)

  • 1. [Role of Ca
    Zhang HX; Han YH; Qiu TT; Yao Y; Zhu SY; Niu MS; Zeng LY; Li ZY; Yan ZL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):717-722. PubMed ID: 31204921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of stromal cells on sentitivity to imatinib in Sup-B15 Philadelphia chromosome positive acute lymphoblastic leukemia cells].
    Zhang H; Chen C; Yan Z; Song X; Chen W; Li D; Qiu T; Zhang P; Zeng L; Li Z; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):460-4. PubMed ID: 26134008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
    Wang Y; Han ZX; Zhang JC
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of VE-cadherin on sensitivity to Imatinib in Sup-B15 Philadelphia chromosome positive acute lymphoblastic leukemia cells].
    Zhang HX; Yan ZL; Song XG; Lü C; Cao J; Li ZY; Zeng LY; Chen C; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):522-6. PubMed ID: 23827112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Roles of Glut5 in Imatinib Resistance in the Ph
    Yan TY; Naren DL; Gong YP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):389-393. PubMed ID: 28616912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI].
    Lin J; Xing HY; Gong YP; Yang X; Guo Y; Shan QQ; Zhou RQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):657-60, 665. PubMed ID: 23230732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.
    Naren D; Wu J; Gong Y; Yan T; Wang K; Xu W; Yang X; Shi F; Shi R
    Leuk Res; 2016 Mar; 42():59-67. PubMed ID: 26818574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph
    Wu JH; Shi FF; Gong YP; Shi R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):216-220. PubMed ID: 28612529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-leukemia effect of oridonin on Ph(+) acute lymphoblastic leukemia cell SUP-B15].
    Guo Y; Shan QQ; Gong YP; Lin J; Yang X; Zhou RQ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):439-43. PubMed ID: 22967375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Huaier Aqueous Extract Combined with Routine Chemo-therapeutic Drugs on Human Acute Lymphoblastic Leukemia Cells Nalm-6 and Sup-B15].
    Qu P; Zhou F; Tan LF; Wang ZJ; Wang ML; Jin RM; Han J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1451-1458. PubMed ID: 33067936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of CD19 expression inhibits proliferation, adhesion, migration and invasion and promotes apoptosis and the efficacy of chemotherapeutic agents and imatinib in SUP-B15 cells.
    Wu J; Liang B; Qian Y; Tang L; Xing C; Zhuang Q; Shen Z; Jiang S; Yu K; Feng J
    Cell Biol Int; 2018 Sep; 42(9):1228-1239. PubMed ID: 29809305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
    Xing H; Yang X; Liu T; Lin J; Chen X; Gong Y
    Leuk Res; 2012 Apr; 36(4):509-13. PubMed ID: 22285507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autophagy induced by curcumin via MEK/ERK pathway plays an early anti-leukemia role in human Philadelphia chromosome-positive acute lymphoblastic leukemia SUP-B15 cells.
    Guo Y; Shan QQ; Gong PY; Wang SC
    J Cancer Res Ther; 2018; 14(Supplement):S125-S131. PubMed ID: 29578162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN.
    Wang WZ; Lin XH; Pu QH; Liu MY; Li L; Wu LR; Wu QQ; Mao JW; Zhu JY; Jin XB
    Biochem Biophys Res Commun; 2014 Nov; 454(3):423-8. PubMed ID: 25451263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of PCI-32765 and Dasatinib on the Acute Lymphoblastic Leukemic Cells and Their Mechanisms].
    Deng Y; Tao SD; Zhang X; Ma JJ; He ZM; Chen Y; Deng ZK; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):72-79. PubMed ID: 28245378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Notch1 Pathway in SUP-B15 Cell Apoptosis Induced by JQ1].
    Wang Y; Ma LM; Wang XZ; Wang T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):364-8. PubMed ID: 25948186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of BRD4 Inhibitor GSK525762A on Proliferation and Apoptosis of SUP-B15 Cells In Vitro and Its Possible Mechanism].
    Wang X; Qi N; Ma S; Yan ZL; Wu QY; Wang L; Chen C; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1654-1658. PubMed ID: 28024472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of 4' -Hydroxywogonin on Proliferation and Apoptosis of Human Acute Lymphoblastic Leukemia Cells].
    Li PF; An XZ; Ma YM; Kong QL; Bao BX; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):65-69. PubMed ID: 29397820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paeoniflorin induces apoptosis and cycle arrest in B-cell acute lymphoblastic leukemia cells by inhibiting SENP1/c-Myc signaling pathway].
    Qin X; Chen X; Liu J; Zeng Y; Guo L; Liu WJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3312-3319. PubMed ID: 35851125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.